GlassScriptPhysician profile
Gregory Todd Moore
NPI 1013108653
$8,584.51
in general payments reported to CMS, 2019-2025
24 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $3,454 · 2021: $53.71 · 2022: $2,505 · 2023: $776 · 2024: $521 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,861 · Travel and Lodging: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,861.34 |
| Travel and Lodging | $581.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $3,967.96 | 2020-2025 | |
| Arthrex, INC. | $2,825.52 | 2022-2023 | |
| Orthofix Medical, INC. | $414.14 | 2021-2025 | Truelok |
| Stryker Corporation | $322.73 | 2021-2025 | Mako, Gamma, Pangea |
| Depuy Synthes Sales INC. | $216.62 | 2019-2025 | |
| Smith+Nephew, INC. | $160.31 | 2025 | Spatial Frame, Novostitch, Acufex Meniscal Root Repair |
| Abbott Laboratories | $137.59 | 2025 | Proclaim |
| Ferring Pharmaceuticals INC. | $79.89 | 2021-2025 | Euflexxa |
| Horizon Therapeutics Plc | $51.22 | 2019-2022 | |
| Heraeus Medical, LLC. | $45.41 | 2022 | |
| Zimmer Biomet Holdings, INC. | $43.14 | 2025 | Echo |
| Becton, Dickinson and Company | $40.70 | 2025 | |
| Dynasplint Systems INC. | $37.89 | 2022 | |
| Next Science LLC | $37.75 | 2025 | Xperience, Blastx |
| Ethicon US, LLC | $35.77 | 2019-2025 | Dermabond Prineo |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $26.99 | 2025 | Exparel |
| Pacira Therapeutics, INC. | $24.95 | 2019 | |
| Boston Scientific Corporation | $20.47 | 2019 | |
| Baxter Healthcare | $19.46 | 2022 | |
| Fx Shoulder Solutions, INC | $17.59 | 2019 | |
| Fidia Pharma USA INC. | $16.66 | 2023 | Triluron, Hymovis |
| Bioventus LLC | $15.43 | 2020 | |
| Hydrocision, INC. | $14.73 | 2024 | Tenjet |
| Onkos Surgical, INC. | $11.59 | 2025 | Eleos Limb Salvage System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.